Point of care testing for infectious diseases
Infectious diseases are caused by pathogenic microorganisms and can be transmitted
between individuals and populations thus threatening the general public health and …
between individuals and populations thus threatening the general public health and …
[HTML][HTML] Tenofovir alafenamide: a novel prodrug of tenofovir for the treatment of human immunodeficiency virus
AS Ray, MW Fordyce, MJM Hitchcock - Antiviral research, 2016 - Elsevier
Despite substantial progress in the development of antiretroviral regimens that durably
suppress Human Immunodeficiency Virus (HIV) infection, new agents that maintain high …
suppress Human Immunodeficiency Virus (HIV) infection, new agents that maintain high …
Methods of public health research—strengthening causal inference from observational data
MA Hernán - New England Journal of Medicine, 2021 - Mass Medical Soc
Methods of Public Health Research For researchers using observational data, a useful way
to answer a causal question is to design the target trial that would answer it and then …
to answer a causal question is to design the target trial that would answer it and then …
Initiation of antiretroviral therapy in early asymptomatic HIV infection
Insight Start Study Group - New England Journal of Medicine, 2015 - Mass Medical Soc
Background Data from randomized trials are lacking on the benefits and risks of initiating
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel
Importance New data and therapeutic options warrant updated recommendations for the use
of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …
of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …
Prevention of HIV-1 infection with early antiretroviral therapy
Background Antiretroviral therapy that reduces viral replication could limit the transmission
of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine …
of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine …
Cohort profile: the women's interagency HIV study (WIHS)
AA Adimora, C Ramirez, L Benning… - International journal …, 2018 - academic.oup.com
The National Institutes of Health established the Women's Interagency HIV Study (WIHS) in
1993 to study the impact and progression of HIV infection among women in response to the …
1993 to study the impact and progression of HIV infection among women in response to the …
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled …
B Grinsztejn, MC Hosseinipour, HJ Ribaudo… - The Lancet infectious …, 2014 - thelancet.com
Background Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related
morbidity and mortality and prevents sexual transmission of HIV-1. However, the best time to …
morbidity and mortality and prevents sexual transmission of HIV-1. However, the best time to …
[PDF][PDF] Test procedures for insecticide resistance monitoring in malaria vector mosquitoes
World Health Organization - 2016 - apps.who.int
Global malaria control efforts have produced remarkable results over the past 15 years. In
2016, there were an estimated 216 million cases of malaria and an estimated 445 000 …
2016, there were an estimated 216 million cases of malaria and an estimated 445 000 …
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial
MS Sulkowski, JJ Eron, D Wyles, R Trinh, J Lalezari… - Jama, 2015 - jamanetwork.com
Importance Patients co-infected with human immunodeficiency virus (HIV) and hepatitis C
virus (HCV) are at high risk for liver disease progression. However, interferon-based …
virus (HCV) are at high risk for liver disease progression. However, interferon-based …